Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance.

Diabetes is associated with defective beta cell function and altered beta cell mass. The mechanisms regulating beta cell mass and its adaptation to insulin resistance are unknown. It is unclear whether compensatory beta cell hyperplasia is achieved via proliferation of existing beta cells or neogenesis from progenitor cells embedded in duct epithelia. We have used transgenic mice expressing a mutant form of the forkhead-O1 transcription factor (FoxO1) in both pancreatic ductal and endocrine beta cells to assess the contribution of these 2 compartments to islet expansion. We show that the mutant FoxO1 transgene prevents beta cell replication in 2 models of beta cell hyperplasia, 1 due to peripheral insulin resistance (Insulin receptor transgenic knockouts) and 1 due to ectopic local expression of IGF2 (Elastase-IGF2 transgenics), without affecting insulin secretion. In contrast, we failed to detect a specific effect of the FoxO1 transgene on the number of periductal beta cells. We propose that beta cell compensation to insulin resistance is a proliferative response of existing beta cells to growth factor signaling and requires FoxO1 nuclear exclusion.

[1]  D. Accili,et al.  FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. , 2005, Cell metabolism.

[2]  Julia M. Francis,et al.  FoxO3a and BCR-ABL Regulate cyclin D2 Transcription through a STAT5/BCL6-Dependent Mechanism , 2004, Molecular and Cellular Biology.

[3]  Senta Georgia,et al.  β cell replication is the primary mechanism for maintaining postnatal β cell mass , 2004 .

[4]  D. Accili,et al.  Transgenic rescue of insulin receptor-deficient mice. , 2004, The Journal of clinical investigation.

[5]  D. Accili.  Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. , 2004, Diabetes.

[6]  Douglas A. Melton,et al.  Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation , 2004, Nature.

[7]  J. Auwerx,et al.  Impaired pancreatic growth, β cell mass, and β cell function in E2F1 –/– mice , 2004 .

[8]  M. Varella‐Garcia,et al.  The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  James D. Johnson,et al.  Increased islet apoptosis in Pdx1+/- mice. , 2003, The Journal of clinical investigation.

[10]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[11]  Y. Kido,et al.  The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. , 2002, The Journal of clinical investigation.

[12]  E. Lam,et al.  Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D , 2002, Molecular and Cellular Biology.

[13]  Y. Kido,et al.  Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. , 2002, The Journal of clinical investigation.

[14]  Y. Kido,et al.  Effects of Mutations in the Insulin-like Growth Factor Signaling System on Embryonic Pancreas Development and β-Cell Compensation to Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[15]  D. Accili,et al.  Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 , 2002, Nature Genetics.

[16]  D. Melton,et al.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.

[17]  E. Ayuso,et al.  β cell expression of IGF-I leads to recovery from type 1 diabetes , 2002 .

[18]  M. Stoffel,et al.  β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.

[19]  M. Iino,et al.  Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca2+] elevation signals , 2002 .

[20]  Graeme I. Bell,et al.  Diabetes mellitus and genetically programmed defects in β-cell function , 2001, Nature.

[21]  M. Permutt,et al.  Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia , 2001 .

[22]  Y. Kido,et al.  Distinct and overlapping functions of insulin and IGF-I receptors. , 2001, Endocrine reviews.

[23]  E. Furth,et al.  Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα , 2001, Nature Medicine.

[24]  O. Madsen,et al.  Improved glucose tolerance and acinar dysmorphogenesis by targeted expression of transcription factor PDX-1 to the exocrine pancreas. , 2001, Diabetes.

[25]  C. Kahn,et al.  Evidence for a circulating islet cell growth factor in insulin-resistant states , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Bertelli,et al.  Association between islets of Langerhans and pancreatic ductal system in adult rat. Where endocrine and exocrine meet together? , 2001, Diabetologia.

[27]  G I Bell,et al.  Diabetes mellitus and genetically programmed defects in beta-cell function. , 2001, Nature.

[28]  S. Aizawa,et al.  Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. , 2000, Diabetes.

[29]  L. Sussel,et al.  Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. , 2000, Development.

[30]  S. Bonner-Weir.  Perspective: Postnatal Pancreatic β Cell Growth. , 2000, Endocrinology.

[31]  F. Talamantes,et al.  Targeted Expression of Placental Lactogen in the Beta Cells of Transgenic Mice Results in Beta Cell Proliferation, Islet Mass Augmentation, and Hypoglycemia* , 2000, The Journal of Biological Chemistry.

[32]  F. Guillemot,et al.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Y. Kido,et al.  Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. , 2000, The Journal of clinical investigation.

[34]  A. F. Stewart,et al.  Hepatocyte Growth Factor Overexpression in the Islet of Transgenic Mice Increases Beta Cell Proliferation, Enhances Islet Mass, and Induces Mild Hypoglycemia* , 2000, The Journal of Biological Chemistry.

[35]  D. Hanahan,et al.  Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. , 1999, The Journal of clinical investigation.

[36]  M. White,et al.  Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. , 1999, The Biochemical journal.

[37]  A. Costantino,et al.  Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells , 1999, Molecular and Cellular Biology.

[38]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[39]  L. Bouwens,et al.  Extra-insular beta cells associated with ductules are frequent in adult human pancreas , 1998, Diabetologia.

[40]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[41]  D. Accili,et al.  Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.

[42]  S. Bonner-Weir,et al.  Dynamics of β-cell Mass in the Growing Rat Pancreas: Estimation With a Simple Mathematical Model , 1995, Diabetes.

[43]  J. H. Johnson,et al.  Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. , 1995, The Journal of biological chemistry.

[44]  Simeon I. Taylor,et al.  Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.

[45]  W. Blaner,et al.  Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.